Hyperglycemia, defined as elevated blood glucose levels, is a key risk factor for multiple cardiovascular and neurological complications. Among these, stroke occupies a central role due to its high mortality and the severe sequelae it can leave in patients.
What is hyperglycemia?
Hyperglycemia occurs when blood glucose levels exceed normal values. Under normal conditions, fasting glucose should be between 70 and 100 mg/dl, while values above 126 mg/dl fasting or above 200 mg/dl after a tolerance test indicate a problem.
Hyperglycemia can be acute or chronic:

-
Acute: it appears temporarily, for example, after an infection, a stress episode, corticosteroid treatment, or in hospitalized patients.
-
Chronic: it is mainly associated with diabetes mellitus and represents a sustained risk factor for vascular and neurological damage.
Hyperglycemia and risk of stroke
Several studies have shown that hyperglycemia significantly increases the risk of stroke. This is because elevated glucose progressively damages blood vessels, promotes thrombus formation, and reduces the brain’s ability to withstand ischemia.
The key points of this relationship are:
-
Patients with diabetes and chronic hyperglycemia have a 2 to 4 times higher likelihood of having a stroke.
-
Acute hyperglycemia in the context of a stroke worsens prognosis, increasing mortality and the degree of disability.
-
Persistent high glucose levels increase the risk of stroke recurrence and subsequent cognitive impairment.
Pathophysiological mechanisms
The connection between hyperglycemia and stroke can be explained by different mechanisms:
-
Accelerated atherosclerosis: elevated glucose promotes plaque formation in cerebral and carotid arteries.
-
Oxidative stress: excess free radicals damage the endothelium and reduce vascular elasticity.
-
Chronic inflammation: hyperglycemia activates inflammatory pathways that weaken the vascular wall.
-
Endothelial dysfunction: blood vessels lose their ability to dilate, reducing cerebral blood flow.
-
Increased risk of thrombosis: elevated glucose alters coagulation and facilitates clot formation.
These processes explain why hyperglycemia not only increases the risk of stroke, but also worsens its consequences when it occurs.
Clinical consequences
The presence of hyperglycemia in stroke patients is associated with worse clinical outcomes:
-
Greater extent of cerebral infarction in cases of ischemic stroke.
-
Worse functional recovery after the acute phase.
-
Increased in-hospital mortality.
-
Higher risk of intracerebral hemorrhage in patients treated with thrombolysis.
-
Accelerated cognitive decline after the event.
Therefore, hyperglycemia is not only a metabolic marker, but also a clinical determinant in the progression of a stroke.
Diagnosis of hyperglycemia

The diagnosis of hyperglycemia is made through blood tests:
-
Fasting plasma glucose: ≥126 mg/dl.
-
Postprandial glucose or 2 hours after an oral glucose tolerance test: ≥200 mg/dl.
-
Glycated hemoglobin (HbA1c): ≥6.5% indicates poor chronic glycemic control.
In patients with stroke, it is recommended to measure blood glucose at hospital admission, as acute hyperglycemia is a predictor of poor prognosis even in individuals without a prior diagnosis of diabetes.
Prevention strategies
Prevention of hyperglycemia is essential to reduce the risk of stroke. The main measures are:
-
Balanced diet: rich in fruits, vegetables, whole grains, and low in simple sugars.
-
Regular physical activity: at least 150 minutes per week of moderate aerobic exercise.
-
Regular medical monitoring: glucose and HbA1c check-ups.
-
Pharmacological treatment: insulin and oral antidiabetic agents when appropriate.
-
Risk factor management: control of blood pressure, cholesterol, and body weight.
Treatment of hyperglycemia in the context of stroke
The management of hyperglycemia during a stroke is a topic of debate. Current evidence suggests:
-
Maintain glucose levels in a range of 140–180 mg/dl in patients hospitalized for stroke.
-
Avoid both severe hyperglycemia (>180 mg/dl) and hypoglycemia (<70 mg/dl), as both are associated with worse prognosis.
-
Adjust insulin therapy on an individualized basis, considering the patient’s clinical condition.
Proper management of hyperglycemia in the acute phase can improve neurological recovery and reduce complications.
Public health impact
Hyperglycemia represents a growing public health problem, as diabetes and metabolic syndrome continue to increase worldwide. The burden of stroke associated with hyperglycemia translates into high healthcare costs, loss of productivity, and deterioration in the quality of life of millions of people.
Preventing and controlling hyperglycemia not only reduces the risk of stroke, but also decreases the incidence of other cardiovascular complications, such as myocardial infarction.
Conclusion
Hyperglycemia is a determining factor in the onset and progression of stroke. Both chronic exposure to high glucose levels and the presence of acute hyperglycemia in the context of a stroke worsen prognosis and increase mortality.
Prevention, early diagnosis, and appropriate treatment of hyperglycemia should be a priority in clinical practice to reduce the incidence of stroke and improve patients’ quality of life.
Maintaining adequate glucose control, along with healthy habits and regular medical follow-up, is the most effective strategy to protect brain and cardiovascular health.
If you would like more information about NeuroAiD II, please fill out this contact form.
"*" indicates required fields